SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGGI (IGG International)with 5.25Billion market?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rocket who wrote (56)5/19/1997 6:36:00 PM
From: Andrew G.   of 96
 
CAMBRIDGE, Mass., May 12 (Reuter) - An independent
evaluation of IGG International Inc's lead carbohydrate-based
anti-fungal compound CAN-296 found the product to be very
promising, IGG said Monday.
It said Jack Sobel, chief of infectious disease at Harper
Hospital and professor of medicine at Wayne State University
School of Medicine, had described CAN-296 as a compound with
enormous potential.
MORE
Rtr 10:27 05-12-97

That's the latest as far as I know, Rocket. My guess is simply that the company is gaining some following and they have not had one announced set-back to date. They are just steamrolling ahead. I'm really quite pleased with the progress. I'm particularly interested in GBC-590. The patients have tolerated it very well, and the next phase is to administer higher, medicinal dosages. 'Really looking forward to more news on that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext